EUVIMEDEUVIMED entdecken
Crossref

Integrating network pharmacology and metabolomics to elucidate the mechanism of allopurinol in hyperuricemia treatment

Yu Xu, Wenqian Ye, Pengyu Tian, Jiangtao Zhou, Zhijia Zhang, Fan Yang iD

Canadian Journal of Physiology and Pharmacology · 2026

DOI: 10.1139/cjpp-2025-0391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2026. Verfasst von Yu Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Sciences and Technology, Taiyuan Normal University, Jinzhong 030619, China. Hauptthemen laut MEDLINE: Allopurinol, Hyperuricemia, Metabolomics, Network Pharmacology. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study integrated network pharmacology and metabolomics to investigate the mechanism of allopurinol in treating hyperuricemia. Therapeutic targets were identified by screening drug and disease databases. A drug–target–disease network was constructed and validated by molecular docking using Cytoscape. A mouse model of hyperuricemia was established with yeast extract and potassium oxonate. Allopurinol efficacy was evaluated via body weight, renal histopathology, and serum biochemical indices. Enrichment analyses of Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways were performed using DAVID platform. Serum metabolite profiles were analyzed by UPLC-Q-TOF/MS-based metabolomics, and metabolic pathways were explored using MetaboAnalyst 6.0. Network pharmacology and molecular docking identified 23 key targets and 43 signaling pathways related to allopurinol treatment. Animal experiments confirmed allopurinol significantly reduced serum levels of uric acid, creatinine, blood urea nitrogen, and xanthine oxidase activity. Metabolomic analysis revealed 5 differentially regulated metabolites and 13 key metabolic pathways associated with allopurinol intervention. The integrated results indicated that allopurinol treats hyperuricemia not only by modulating purine metabolism but also potentially through influencing oxidative stress and apoptosis-related pathways. This study provided preliminary experimental insights into the potential mechanistic basis of allopurinol in the treatment of hyperuricemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllopurinolHyperuricemiaMetabolomicsNetwork PharmacologyAnimalsMiceMolecular Docking SimulationXanthine OxidaseKidneyMaleUric AcidMetabolic Networks and Pathways

Stichwörter der Autor:innen

allopurinolhyperuricemiametabolomicsmolecular dockingnetwork pharmacology

Substanzen

AllopurinolXanthine OxidaseUric Acid

Autor:innen und Institutionen

  • College of Biological Sciences and Technology, Taiyuan Normal University, Jinzhong 030619, China.
  • School of Pharmacy, Shanxi Medical University, Taiyuan 030001, China.
  • Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China.
  • The Fifth Clinical Medical College of Shanxi Medical University, Shanxi Provincial People's Hospital, Taiyuan 030001, China.

ORCID-Profile: Fan Yang

Zitieren

APA

Xu, Y., Ye, W., Tian, P., Zhou, J., Zhang, Z., & Yang, F. (2026). Integrating network pharmacology and metabolomics to elucidate the mechanism of allopurinol in hyperuricemia treatment. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2025-0391

Vancouver

Xu Y, Ye W, Tian P, Zhou J, Zhang Z, Yang F. Integrating network pharmacology and metabolomics to elucidate the mechanism of allopurinol in hyperuricemia treatment. Canadian Journal of Physiology and Pharmacology. 2026. doi:10.1139/cjpp-2025-0391

BibTeX
@article{Xu2026,
  author = {Xu, Yu and Ye, Wenqian and Tian, Pengyu and Zhou, Jiangtao and Zhang, Zhijia and Yang, Fan},
  title = {Integrating network pharmacology and metabolomics to elucidate the mechanism of allopurinol in hyperuricemia treatment},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2026},
  doi = {10.1139/cjpp-2025-0391}
}
Kostenlos starten →